New drug combo tested to fight advanced kidney cancer
NCT ID NCT03172754
Summary
This study is testing whether combining two existing drugs, nivolumab and axitinib, is safe and effective for treating advanced kidney cancer. It will involve about 98 patients, including those who have had prior treatment and those who have not. The first part finds the safest dose, and the second part checks how well the combination works at that dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cornell
New York, New York, 10021, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Johns Hopkins
Baltimore, Maryland, 21231, United States
-
US Oncology and Hematology
Albany, New York, 12206, United States
Conditions
Explore the condition pages connected to this study.